PRPeptide Evidence ReferenceEVIDENCE-GRADED · EDUCATIONAL
Educational reference only — not medical advice. Nothing is sold on this site. Research compounds are not for human use.
Home>>Reference>>FDA-Approved Peptide and Injectables Reference

FDA-Approved Peptide and Injectables Reference

Compounds in this catalog that exist as approved medicines in the United States or other major jurisdictions — with their key approved brand names and indications.

CompoundApproved brand examplesKey approved indications
SemaglutideOzempic / Wegovy / RybelsusType 2 diabetes; chronic weight management
TirzepatideMounjaro / ZepboundType 2 diabetes; chronic weight management
LiraglutideVictoza / SaxendaType 2 diabetes; chronic weight management
DulaglutideTrulicityType 2 diabetes; cardiovascular risk reduction
TeriparatideForteoOsteoporosis at high fracture risk
TesamorelinEgrifta SVExcess abdominal fat in HIV lipodystrophy
SomatropinGenotropin, Norditropin, othersGrowth hormone deficiency and related growth disorders
Insulin analogsHumalog, Lantus, Tresiba, othersDiabetes mellitus
OxytocinPitocinLabor induction; postpartum hemorrhage
AlprostadilCaverject / Muse / Prostin VRErectile dysfunction; ductus arteriosus (neonatal)
Bremelanotide (PT-141)VyleesiAcquired, generalized HSDD in premenopausal women
Afamelanotide (MT-I)ScenesseErythropoietic protoporphyria
Epoetin alfa and biosimilarsEpogen / Procrit / RetacritAnemia of chronic kidney disease and others
Chorionic gonadotropin (HCG)Pregnyl, NovarelFertility induction; hypogonadotropic hypogonadism
Menotropins (HMG)Menopur / RepronexControlled ovarian stimulation
TriptorelinTrelstar / TriptodurAdvanced prostate cancer; precocious puberty
GonadorelinFactrel (historical)Diagnostic pituitary stimulation
Botulinum toxinsBotox / Dysport / XeominCosmetic and therapeutic chemodenervation
LevocarnitineCarnitorPrimary and secondary carnitine deficiency
Cyanocobalamin (B12)Multiple approved productsVitamin B12 deficiency
Hyaluronic acid fillersJuvederm / Restylane familiesFacial wrinkles and volume correction (device-regulated)
This table is a navigation aid into the entry pages, which carry full evidence and safety context for each compound.
EM
Dr. Elena Marsh, PhDMolecular Pharmacology · Lead Editor

Written and maintained by the editorial team. Medically reviewed by Dr. James Okafor, MD (Internal Medicine).

Evidence tier: Approved medicine · Last reviewed: 2026-09-05 · Sources cited below.

Advertisement